91 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
at least 4.5-fold versus the TAT-ANC at lower doses. These long-term hematological improvements correlated with fewer infections and reduced numbers … that long-term treatment with mavorixafor was well tolerated and continued to demonstrate beneficial treatment effects, including decreased frequency
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Regulation FD Disclosure
8:30am
syndrome1,2 G-CSF and IVIg associated with burdensome administration Long-term use of antibiotics associated with risk of developing antimicrobial … nature of the treatment Oral formulation of HCPs believe WHIM syndrome is a serious immune disorder with potential for long-term complications 92% HCP
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
21 Mar 24
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial
7:43am
of long-term debt
Total current liabilities
Long-term debt, including accretion, net of discount
Lease liabilities
Other liabilities
Total liabilities
8-K
EX-99.1
ksgvk2
9 Nov 23
X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
8:07am
8-K
EX-99.1
7vapn0hv p8bi
10 Aug 23
Provides Corporate Updates, and Reports Emerging Data from
6:41am
8-K
EX-99.1
snujum7aemk0e0tix
4 May 23
X4 Pharmaceuticals Reports First-Quarter 2023 Financial
9:05am
8-K
EX-99.1
toj0p5b2d1c3jl tv7h
4 May 23
X4 Pharmaceuticals Reports First-Quarter 2023 Financial
6:42am
8-K
EX-1.1
tp08ijqhm
9 Dec 22
X4 Pharmaceuticals Announces Proposed Public Offering
8:46am
424B5
85r 6fjelpaan
8 Dec 22
Prospectus supplement for primary offering
5:47pm
424B5
fqz1y
6 Dec 22
Prospectus supplement for primary offering
9:52pm
8-K
EX-99.2
lzhfssrsxs
29 Nov 22
X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome
4:05pm
8-K
EX-99.1
nq0p7pk
3 Nov 22
X4 Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:21am
8-K
EX-99.1
8yvxada8rol 0d3d70
27 Sep 22
Regulation FD Disclosure
7:53am